Leslie M. Gouthro practices in the Firm's Complex Litigation, Pharmaceutical Products, and Toxic Torts & Products Liability groups. Her practice extends to commercial litigation, including construction and engineering disputes, breach of contract and design claims, and business torts in multidistrict litigation. Read More >
Hollingsworth LLP outwits well-funded plaintiffs' attorney group by prevailing in early trials (including plaintiffs' trial picks) in consolidated litigation for client Novartis Pharmaceuticals Corporation.
11th Circuit affirmance in Rider v. Sandoz Pharmaceuticals completes circuit court Daubert sweep in Parlodel® litigation.
Avondale Mills, Inc. v. Norfolk Southern Corp., Civ. No. 1:05-2817-MBS (D.S.C. 2008)
New Mexico v. Gen. Electric Co., 467 F.3d 1223 (10th Cir. 2006)
Allgood v. General Motors Corp., No. 1:02-cv-1077-DFH-TAB (S.D. Ind. Sept. 18, 2006)
Verdicts & Opinions
Stirling v. Novartis Pharm. Corp., No. CV01-18-4880 (Idaho 4th Jud. Dist., Ada Cty. July 13, 2020)
Coleson v. Novartis Pharm. Corp., No. 3:18-cv-00359, (S.D. Miss. June 29, 2020)
Johnson v. Novartis Pharm. Corp., et al., No. 5:19-cv-01087-OLG (May 7, 2020).
Stirling v. Novartis Pharm. Corp., et al., No. CV01-18-4880 (Sept. 25, 2019)
Brad Lafferty, et al. v. The Sherwin-Williams Company, et al., Case No. 1:17-cv-06321, at *8 (D.N.J. Aug. 21, 2018)
News & Publications
Gregory S. Chernack, Robert E. Johnston, and Anna G. Kornilova for DRI's Daubert Online
Mr. Dhindsa serves on the University of Maryland Francis King Carey School of Law Board of Visitors
Mr. Lasker's comments are in further support of his 2015 Law Review article calling for an amendment to FRE Rule 702 and a 2018 Advisory Committee presentation sponsored by the Judicial Conference Advisory Committee on Rules of Evidence.